[NBIX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 34.29%
YoY- -1,516.11%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 138,403 71,086 0 15,000 19,769 0 730 139.58%
PBT -102,594 -41,818 -78,326 -19,264 -1,192 -11,842 -12,075 42.82%
Tax -479 7,504 -1,606 -1,593 -1,340 -1,061 -898 -9.94%
NP -102,115 -41,818 -78,326 -19,264 -1,192 -11,842 -12,075 42.71%
Tax Rate - - - - - - - -
Total Cost 240,518 112,904 78,326 34,264 20,961 11,842 12,805 63.00%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -73.78 -58.83 0.00 -128.43 -6.03 0.00 -1,654.11 -40.43%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -1.12 -0.47 -0.90 -0.22 -0.01 -0.17 -0.18 35.60%
EPS Diluted -1.12 -0.47 -0.90 -0.22 -0.01 -0.17 -0.18 35.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.